Abstract
Igor Aleksandrovich Makarov, Yulia ROY, Lubov Borisovna Mitrofanova
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Therapeutic landscape of Fabry disease: advances and challenges from classical strategies to emerging therapies
10.3389/fmed.2025.1662867 · 2025
Clinical phenotypes of Fabry disease in adult men and women
10.32756/0869-5490-2025-2-31-36. · 2025
Characterization of classical and nonclassical Fabry disease: a multicenter study
10.1681/asn.2016090964 · 2017
10.15420/cfr.2023.06
10.15420/cfr.2023.06
Diagnosis and management of cardiovascular involve-ment in Fabry disease
10.1016/j.hfc.2021.07.005 · 2022
Anderson-Fabry cardiomyopathy: prevalence, patho-physiology, diagnosis and treatment
10.1007/s10741-014-9452-9 · 2015
Cardiac manifestation of Fabry disease: from hypertrophic cardiomyo-pathy to early diagnosis and treatment in patients without left ventricular hypertrophy
10.1177/2326409816661352 · 2016
Differential diagnosis of left ventricular hypertrophy: usefulness of multimodality imaging and tissue characterization with cardiac magnetic reso-nance
10.1111/echo.13367 · 2016
Cardiomyopathy associated with the Ala143Thr variant of the α-galactosidase A gene
10.1136/heartjnl-2019-315933 · 2020
Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations
10.21037/cdt-20-593 · 2021
10.1161/circgenetics.116.001691
10.1161/circgenetics.116.001691
Unexplained left ventricular hypertrophy with symptomatic high-grade atrioven-tricular block in elderly patients: a case report
10.3390/jcm11123522 · 2022
Usefulness of elec-tron microscopy in the diagnosis of heterozygous Fabry disease with left ventricular outflow tract obstruction masquerading as hypertrophic cardiomyopathy
10.1016/j.carpath.2025.107809 · 2026
Dependence of the heart weight on the body weight in patients with car-diovascular diseases
10.1023/b:hump.0000036337.59404.b5 · 2004
Postmortem heart weight: relation to body size and effects of cardiovascular disease and cancer
10.1016/j.carpath.2013.09.001 · 2014
Postmortem heart weight: relation to body size and effects of cardiovascular disease and cancer
10.1016/j.carpath.2013.09.001 · doi-reference
Dependence of the heart weight on the body weight in patients with car-diovascular diseases
10.1023/b:hump.0000036337.59404.b5 · doi-reference
Usefulness of elec-tron microscopy in the diagnosis of heterozygous Fabry disease with left ventricular outflow tract obstruction masquerading as hypertrophic cardiomyopathy
10.1016/j.carpath.2025.107809 · doi-reference
Unexplained left ventricular hypertrophy with symptomatic high-grade atrioven-tricular block in elderly patients: a case report
10.3390/jcm11123522 · doi-reference
10.1161/circgenetics.116.001691
10.1161/circgenetics.116.001691 · doi-reference
Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations
10.21037/cdt-20-593 · doi-reference
Cardiomyopathy associated with the Ala143Thr variant of the α-galactosidase A gene
10.1136/heartjnl-2019-315933 · doi-reference
Differential diagnosis of left ventricular hypertrophy: usefulness of multimodality imaging and tissue characterization with cardiac magnetic reso-nance
10.1111/echo.13367 · doi-reference
Cardiac manifestation of Fabry disease: from hypertrophic cardiomyo-pathy to early diagnosis and treatment in patients without left ventricular hypertrophy
10.1177/2326409816661352 · doi-reference
Anderson-Fabry cardiomyopathy: prevalence, patho-physiology, diagnosis and treatment
10.1007/s10741-014-9452-9 · doi-reference
Diagnosis and management of cardiovascular involve-ment in Fabry disease
10.1016/j.hfc.2021.07.005 · doi-reference
10.15420/cfr.2023.06
10.15420/cfr.2023.06 · doi-reference
Characterization of classical and nonclassical Fabry disease: a multicenter study
10.1681/asn.2016090964 · doi-reference
Clinical phenotypes of Fabry disease in adult men and women
10.32756/0869-5490-2025-2-31-36. · doi-reference
Therapeutic landscape of Fabry disease: advances and challenges from classical strategies to emerging therapies
10.3389/fmed.2025.1662867 · doi-reference